en.wikipedia.org/wiki/Otsuka_Pharmaceutical

Otsuka Pharmaceutical Co., Ltd (TYO: 4578), abbreviated OPC, is a pharmaceutical company ... Otsuka's subsidiary Otsuka America will pay $100 million upfront for Neurovance, plus up-to $150 million in development and approval milestones ...

www.otsuka-us.com

Otsuka in the U.S. From a family business to a global pharmaceutical business. Research and development of new pharmaceutical products and Digital Medicine. Fulfil your dreams with ... Otsuka America Pharmaceutical, Inc. 2440 Research ...

www.otsuka-us.com/discover/oapi

OAPI commercializes Otsuka-developed and in-licensed products for use in ...

www.otsuka-us.com/products-solutions-and-patient-support/our-medicines

In the United States, Otsuka markets products that have been either developed, ...

www.otsuka-us.com/careers-and-talent/career-opportunities

Career Opportunities. Join the Otsuka Family: Make a Difference. Otsuka offers  ...

www.otsuka-us.com/discover/otsuka-us

Otsuka in the U.S. has two companies that carry out research, clinical ...

www.otsuka-us.com/discover/overview

Otsuka in the U.S. develops and promotes pharmaceutical products and  ...

www.otsuka-us.com/faqs

This website uses cookies to optimize site functionality and enhance your ...

www.otsuka-america.com/company/oapi.html

OAPI oversees commercial activities in the U.S. with a focus on developing products in neuroscience, oncology, and cardio-renal. It is our goal to deliver the  ...